Norwegian Cruise Line Holdings Opens Shareholder Q&A Platform Ahead Of NYC Investor Event


(MENAFN- GlobeNewsWire - Nasdaq)

MIAMI, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd.,“Norwegian Cruise Line Holdings” or the“Company”) announced today its new shareholder Q&A and engagement platform is now open for questions ahead of its investor & analyst event being held on Thursday, October 6th at 10 a.m. Eastern Time. Starting today, all NCLH shareholders can submit and upvote questions by visiting: . The Q&A platform will remain open until October 4, at 8:00 a.m. Eastern Time.

Management will address a selection of top ranked, appropriate, questions relating to business and financial results or strategic priorities during the upcoming event. Attendance at the live investor event is by invitation only. The event will be simultaneously live streamed to all interested parties via the Company's Investor Relations website . A replay of the event, including the related slide presentations, will be available on the Company's website for 30 days following the event.

About Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 29 ships with nearly 62,000 berths, these brands offer itineraries to approximately 500 destinations worldwide. The Company has eight additional ships scheduled for delivery through 2027, comprising approximately 20,000 berths.

Investor Relations and Media Contacts
Jessica John
(305) 468-2339

 




MENAFN26092022004107003653ID1104928442


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.